ME SUD Learning Community Project ECHO: Increase Access to MAT/MOUD for Adolescents
Note that this ECHO has begun but if you are interested in joining, please contact: Kate Chichester, Executive Director, CCSME, cchichester@ccsme.org
The Co-Occurring Collaborative Serving Maine in partnership with the Maine Department of Health and Human Services is launching Project ECHO: Increase Access to Medication for Addiction Treatment (MAT) for Adolescents. This Project ECHO is funded through the ME Substance Use Disorder Learning Community by the Maine Department of Health and Human Services. The purpose of the ME SUD Learning Community is to support Prescribing Clinicians and their Teams to provide evidence-based treatment to individuals and their families affected by Substance Use Disorders and Opioid Use Disorder (SUD/OUD) to increase access to treatment and reduce drug overdose deaths. The Statewide SUD Learning Community offers an array of education and support modalities for Prescribers and their entire Practice Teams, including this Project ECHO Program.
This six-month Project ECHO brings together Prescribers and their Teams who may be in various phases of MAT implementation to learn, teach and support each other in their efforts to increase access to MAT for adolescents.
Project ECHO:
Project ECHO® (Extension for Community Healthcare Outcomes) is a guided practice model developed by the University of New Mexico’s Health Sciences Center to increase knowledge and skills. This approach involves case-based learning across expert faculty and participants through regularly scheduled meetings via video conferencing.
Intended Audience:
Prescribers, including X-waivered primary care and specialty care MAT prescribers treating adolescents, those who are interested in newly offering MAT services, and their team members from practices located in Maine who seek support to develop, implement, improve, and sustain OUD/SUD treatment for adolescents.
Learning objectives:
• Bolster skills to appropriately identify and treat SUDs within adolescent populations, including specialty populations of adolescent girls and LBGTQ+ people;
• Build competencies to deliver trauma-informed SUD/MAT care from screening to navigating consent and confidentiality to treatment;
• Strengthen confidence to deliver integrated MAT services in the adolescent population; and
• Expand understanding of harm reduction and diversion practices in the adolescent population.
Commitment:
• Participate in six (6) one-hour monthly case-based learning sessions using a virtual meeting platform (Zoom)
• Each Practice Care Team to present at least one de-identified patient case presentation
• Complete a pre-assessment and post-assessment at the beginning and end of the program.
• Provide requested data points for baseline, quarterly and post-session measurement:
o numberer of patients being treated with MAT/MOUD by the participating provider and by practice
o Number of providers in the clinic who are X-waivered
o Confidence and competency ratings for delivery of MAT/MOUD in adolescents
• Complete evaluation surveys to help with ongoing quality improvement efforts.
• Participants can receive one hour of Category 1 AMA CME credit or one contact hour for each virtual learning session attended
Program Schedule:
Sessions will be held on a monthly schedule outlined below. Sessions will be held on the first Wednesday of each month from 12 Noon – 1 PM and will include a brief didactic presentation from an ECHO faculty member on a pre-determined topic, followed by a case presentation from a Practice Care Team member and Prescriber. An orientation will be scheduled and recorded for those unable to attend.
• Wednesday, May 4, 12 Noon – 1 PM
• Wednesday, June 1, 12 Noon – 1 PM
• Wednesday, July 6, 12 Noon – 1 PM
• Wednesday, August 3, 12 Noon – 1 PM
• Wednesday, September 7, 12 Noon – 1 PM
• Wednesday, October 5, 12 Noon – 1 PM
Throughout this ECHO, the individualized needs of specific populations will be considered, including but not limited to the needs of the LGBTQ+ and adolescent girls.
Topics:
• Screening for OUD, SUDs, MH (co-occurring) & risk behaviors
• Assessment of OUD/SUD & MH
• Informed consent and confidentiality
• Induction and stabilization of buprenorphine in adolescents
• Continuation of the Adolescent and Parent Supports/Parent Guidance in MAT and Treatment
• Harm reduction/diversion mitigation for youth
Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Maine Medical Education Trust and CCSME. The Maine Medical Education Trust is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.
• 1 contact hour for social workers, licensed clinical professional counselors, and behavioral health professionals
• 1 Category I contact hour for psychologists are provided. CCSME is a pre-approved sponsor and provider of Professional Education Activities for Psychologists.
• 1 contact hour CHES. CCSME is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.
• 1 contact hour pending for alcohol and drug counselors from the board of alcohol and drug counselors
Speakers
-
Adrienne CarmackMD
Dr. Adrienne Carmack, MD, is a provider at Penobscot Pediatrics and the current Medical Director of PCHC’s Key Clinic and CHAMP Clinic. She has a special interest for children in foster care and families struggling with substance use disorder, including substance exposed newborns. She is actively involved in the Maine Chapter of American Academy of Pediatrics. Dr. Carmack and her husband moved to Bangor in 2005 with their 6 children. They love spending time with their children – especially in the outdoors of Maine – and enjoy traveling to see family. Her hobbies include reading, walking, and photography.
-
Amy WestMSN, FNP-C
Amy West, MSN, FNP-C, joined PCHC in 2016. She has special interests in adolescent health, women’s health, and homeless medicine.
-
Ben StrickDirector of Adult Behavioral Health at Spurwink
Director of Adult Behavioral Health at Spurwink
-
Eric HaramLADCEric Haram, LADC is owner of Haram Consulting LLC, whose aim is to improve community health and safety from the impact of substance use disorders, by providing consulting and technical assistance in the areas of strategic planning, workforce development and systems improvement for States, Counties and Organizations. Eric has 30 years experience delivering, designing, and directing substance use treatment services in hospitals, correctional facilities, court systems and community behavioral health centers. Haram Consulting, LLC provides consultation in 11 states, from California to West Virginia, including his home state of Maine where he directs behavioral health services for York Hospital.
-
Jessica CalihanMD
Dr. Jessica B. Calihan is an internal medicine/pediatric specialist in Boston, Massachusetts. She received her medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice between 6-10 years.
-
Jonathan T FanburgMD, MPH
Maine Medical Partners | MMP South Portland Pediatrics
Pediatrics | Adolescent Medicine -
Madeline ShileyYouth Substance Use Disorder (SUD) Specialist for the State of Maine
Youth Substance Use Disorder (SUD) Specialist for the State of Maine
-
Miriam SchizerMD, MPH
Boston Children’s Hospital
Attending Physician, Division of Developmental Medicine
Instructor of Pediatrics, Harvard Medical School
-
Patricia SchramMD
Boston Children’s Hospital
Attending Physician, Division of Developmental Medicine
Instructor in Pediatrics, Harvard Medical School
-
Sharon LevyMD, MPH
Sharon Levy, MD, MPH is a board certified Developmental-Behavioral Pediatrician and an Assistant Professor of Pediatrics at Harvard Medical School. She is the Director of the Adolescent Substance Abuse Program (ASAP) in the Division of Developmental Medicine at Boston Children’s Hospital, which is comprised of clinical, research, training and policy arms. She has evaluated and treated thousands of adolescents with substance use disorders, and has taught national curricula and published extensively on the outpatient management of substance use disorders in adolescents, including screening and brief advice in primary care, the use of drug testing and the outpatient management of opioid dependent adolescents. She is currently the co-PI of a SAMHSA-funded adolescent SBIRT project, an NIAAA-funded study validating the youth alcohol screening tool in a population of youth with chronic medial illness, and a Conrad N. Hilton funded study that aims to validate adolescent SBIRT measures and test a brief intervention for medically vulnerable youth.
